Cerro Pacific Wealth Advisors LLC Pfizer Inc Transaction History

Cerro Pacific Wealth Advisors LLC

$273 Million
Q3 2024

A detailed history of Cerro Pacific Wealth Advisors LLC transactions in Pfizer Inc stock. As of the latest transaction made, Cerro Pacific Wealth Advisors LLC holds 7,343 shares of PFE stock, worth $192,680. This represents 0.08% of its overall portfolio holdings.

Number of Shares

7,343

Previous 7,343 -0.0%

Holding current value

$192,680

Previous $205,000 3.41%

% of portfolio

0.08%

Previous 0.08%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	SELL	$25.26 - $29.6 $90,355 - $105,879	-3,577 Reduced 32.76%	7,343 $205,000
Q1 2023 May 10, 2023	SELL	$39.39 - $51.28 $300,033 - $390,599	-7,617 Reduced 41.09%	10,920 $445,000
Q4 2022 Jan 18, 2023	SELL	$41.75 - $54.5 $70,432 - $91,941	-1,687 Reduced 8.34%	18,537 $0
Q3 2022 Oct 12, 2022	BUY	$43.76 - $53.42 $224,707 - $274,311	5,135 Added 34.03%	20,224 $885,000
Q2 2022 Jul 18, 2022	SELL	$46.53 - $55.17 $235,023 - $278,663	-5,051 Reduced 25.08%	15,089 $791,000
Q1 2022 Apr 13, 2022	SELL	$45.75 - $56.69 $8,692 - $10,771	-190 Reduced 0.93%	20,140 $1.04 Million
Q4 2021 Jan 19, 2022	BUY	$41.32 - $61.25 $10,784 - $15,986	261 Added 1.3%	20,330 $1.2 Million
Q3 2021 Nov 09, 2021	BUY	$39.25 - $50.42 $268,077 - $344,368	6,830 Added 51.59%	20,069 $863,000
Q2 2021 Aug 16, 2021	BUY	$35.91 - $40.68 $199,120 - $225,570	5,545 Added 72.07%	13,239 $518,000
Q4 2020 Feb 12, 2021	BUY	$33.47 - $42.56 $257,518 - $327,456	7,694 New	7,694 $283,000

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.73B

Call Options Held

73.5M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $147B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cerro Pacific Wealth Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cerro Pacific Wealth Advisors LLC with notifications on news.

Account

Cerro Pacific Wealth Advisors LLC Pfizer Inc Transaction History